The above is a list of Cancer Research
CRUK/10/030: TRICON8 - Sample collection of ovarian cancer tissues and blood for translational research from patients participating in the CR-UK/MRC ICON8 trial University of Cambridge 01/01/2013
Personalised biomarkers of response in high-grade serous ovarian cancer University of Cambridge 01/04/2013
Functional genomics of ovarian cancer Cancer Research UK Cambridge Institute 01/10/2011
CRUK/13/012: Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma (ACTICCA-1 trial) (supported by Stand Up To Cancer) University of Birmingham 01/04/2015
Brierley-Jones, Dr Lyn Direct2Deaf: Cancer Prevention In BSL (British Sign Language)
Brindle, Professor Kevin kmb1001**[ta]**.ac.uk
The CRUK & EPSRC Cancer Imaging Centre in Cambridge & Manchester University of Cambridge 01/12/2013
Molecular Imaging Groups Cancer Research UK Cambridge Institute 01/04/2014
Brock, Dr Penelope CRUK/07/023: SIOPEL 6: A randomised phase III trial of the efcacy of sodium thiosulphate in reducing ototoxicity in patients receiving cisplatin chemotherapy for
Brognard, Dr John Signalling Networks in Cancer Cancer Research UK Manchester Institute 01/08/2010
LZK: A Novel Target for Therapeutic Intervention in Head and Neck Squamous Cell Carcinoma University of Manchester 01/03/2015
Brown, Dr Jamie jamie.brown**[ta]**.ac.uk
The ‘real-world’ associations between e-cigarette use and smoking cessation: A prospective cohort study University College London 01/03/2015
Brown, Professor Janet Exploratory and preclinical development and a Phase I frst in human clinical study to evaluate the biological effects of Ad[I/PPT-E
The above is a list of Cancer Research
Clinical Trials and Advisory Committee (CTAAC) Clinical Trials Fellowship: Leeds Clinical Trials Research Unit application University of Leeds 01/07/2015
Brown, Professor Karen kb20**[ta]**ac.uk
Biomarker-driven development of cancer chemopreventive agents: a new paradigm University of Leicester 01/07/2011
Brown, Professor Robert b.brown**[ta]**erial.ac <mailto:b.brown**[ta]**erial.ac>.uk
Mechanisms of Drug Resistance and Epigenetic
Bryan, Dr Richard r.t.bryan**[ta]**nternet.com CRUK/11/027: The collection of biospecimens from patients eligible for the "POUT" clinical trial in upper urinary tract urothelial carcinoma University of Birmingham 01/02/2014
Bubeck, Dr Doryen d.bubeck**[ta]**erial.ac.uk
A structural approach to visualising complementmediated pore-formation Imperial College London 01/01/2014
Buczacki, Mr Simon Simon.Buczacki**[ta]**k.cam.ac.uk
Manipulating the quiescent cancer stem cell niche in colorectal
Burchill, Professor Susan s.a.burchill**[ta]**ds.ac.uk
Qualifcation of target mRNAs as prognostic and predictive biomarkers in children with high-risk neuroblastoma University of Leeds 01/09/2014
Burke, Dr Gladstone amos.burke**[ta]**enbrookes.nhs.uk
CRUK/11/038: Intergroup trial for children or adolescents with B-cell NHL or B-AL: evaluation of rituximab efcacy in high risk patients (Inter-B-NHL ritux 2010) University of Birmingham 01/11/2012
Burn, Professor Sir John john.burn**[ta]**.ac.uk
CRUK/12/039: CaPP3 - a double blind randomised controlled dose inferiority trial of aspirin prevention in people with Lynch syndrome: high risk of cancer due to mutations in the mismatch repair genes (supported by Stand Up To Cancer) Newcastle University 01/09/2013
Burnet, Professor Neil Distinguishing physical and biological determinants of radiotherapy toxicity (Vox Tox).University of Cambridge 01/06/2012
Buykx, Dr Penny p.f.buykx**[ta]**feld.ac.uk
To investigate public knowledge of the link between alcohol and cancer and to examine public attitudes towards alcohol policy University of Shefeld 01/06/2015
Calado, Dr Dinis Immunity and Cancer The Francis Crick Institute 01/03/2013
The above is a list of Cancer Research
Trans-PERSEPHONE and Trans-PERSEPHONE-SNPs: the pharmacogenomics and pharmacogenetics of adjuvant trastuzumab.University of Cambridge 01/04/2008
Breast cancer genomics Cancer Research UK Cambridge Institute 01/06/2013
Caldecott, Professor Keith k.w.caldecott**[ta]**sex.ac.uk
Non-homologous End-Joining Protein Complexes and
Callister, Dr Matthew matthew.callister**[ta]**dsth.nhs.uk
reSEARCH: A biorepository to provide RE agents for the discovery of molecular predictors of lung tumour development, collected in the Lung-SEARCH trial University of Leeds 01/10/2007
Calton, Dr Elizabeth elizabeth.calton**[ta]**.ac.uk
Determining the Clonality of Stage 4S Neuroblastoma Institute of Cancer Research 01/02/2015
Cameron, Professor David d.cameron**[ta]**ac.uk
CRUK/13/010: UNIRAD Sample Collection Institute of Cancer Research 01/08/2015
The influence of a negative FOBT on the response of screening invitees and healthcare providers to symptoms of colorectal cancer.University of Edinburgh 01/07/2012
An enhanced role for primary care in bowel cancer screening: development and testing of a brief intervention for non-responders University of Edinburgh 01/04/2013
Vitamin D regulation of growth control biomarkers in human colon and colorectal cancer (CRC) Queen's University Belfast 01/01/2013
Cardwell, Dr Chris c.cardwell**[ta]**.ac.uk
A novel, integrated, bioinformatics and pharmacoepidemiology approach to identifying and testing medications with potential breast cancer carcinogenicity, or anti-cancer properties Queen's University Belfast 01/09/2014
Carroll, Dr Jason jason.carroll**[ta]**k.cam.ac.uk
Nuclear Receptor Transcription Laboratory Cancer Research UK Cambridge Institute 01/10/2010
Cass, NULL Suzanne 'Towards a smoke-free generation' - building on ASH Wales's collaborative tobacco control campaigns programme This project will be led by ASH Wales's Head of Communications and Public Affairs Action on Smoking and Health (Wales) 01/08/2014
The above is a list of Cancer Research
CRUKE/13/030: PROVENT - A randomised, double blind, placebo controlled feasibility study to examine the clinical effectiveness of aspirin and/or Vitamin D to prevent disease progression in men on Active Surveillance for low risk prostate cancer Queen Mary, University of London 01/07/2014
Cerundolo, Professor Vincenzo vincenzo.cerundolo**[ta]**.ox.ac.uk
Development of vaccination strategies to enhance tumour specifc immune responses University of Oxford 01/01/2015
Chalmers, Professor Anthony anthony.chalmers**[ta]**sgow.ac.uk
CRUKE/13/034: PARADIGM: OlaPArib And RADiotherapy In newly-diagnosed GlioblastoMa (AZ/ NCRN) University of Glasgow 01/02/2014
Identifying and validation of novel targets for overcoming radiation resistance of glioblastoma stem cels under normoxia and
Chambers, Dr Anna The function of the Irc5 subfamily of chromatin remodelling enzymes in DNA repair.University of Bristol 01/10/2014
Chambers, Dr Stephanie stephanie.chambers**[ta]**sgow.ac.uk
Growing
Chesler, Dr Louis louis.chesler**[ta]**.ac.uk
Targeting the ALK-F
Improving outcomes for childhood neuroblastoma - development of therapeutics targeting MYCN, ALK and tumour-initiating pathways Institute of Cancer Research 01/04/2015
CRUK/08/015: TOTEM: A Phase I/II trial of the mTOR inhibitor temsirolimus (CCI-779; Torisel) plus Cisplatin and Gemcitabine as frst line therapy for advanced bladder cancer (and other urothelial cell carcinomas) Cardiff University 01/02/2008
CRUKD/12/009: FIESTA: FGFR Inhibition in Epithelial Solid Tumours - AZD
Chua, Dr Sue CRUKD/12/002: A phase I/II proof-of-concept study to compare the novel technique [124I]mIBG PET/CT to [123I]mIBG scintigraphy in paediatric patients with metastatic neuroblastoma Royal Marsden NHS Foundation Trust 01/12/2010
The above is a list of Cancer Research
CRUK/10/030: ICON 8: An international 2-stage randomised trial of dose-fractionated CT compared to standard 3-weekly CT, following immediate primary surgery or as part of delayed primary surgery, for women with epithelial ovarian University College London 01/04/2011
CRUK/13/023: ICON8B: A phase III randomised trial investigating the combination of dose-fractionated CT + bev compared to either strategy alone for the frstline treatment of women with ovarian cancer University College London 01/05/2014
Clarke, Professor Alan Modelling colorectal cancer in the mouse: assessing pathway synergies and antagonisms in vivo and validating therapeutic targets Cardiff University 01/07/2013
Clarke, Professor Paul p.r.clarke**[ta]**dee.ac.uk
Control of cell death during mitosis and in response to anti-mitotic drugs.University of Dundee 01/06/2012
Clifford, Professor Steven steve.clifford**[ta]**.ac.uk
Biomarker-driven individualisation of medulloblastoma therapy Newcastle University 01/04/2012
Coleman, Dr Helen h.coleman**[ta]**.ac.uk
The role of tumour vitamin D receptor expression, vitamin D related genetic variation and vitamin D supplement use in colorectal cancer survival Queen's University Belfast 01/01/2013
Coleman, Professor Michel michel.coleman**[ta]**tm.ac.uk
Global surveillance of cancer survival (CONCORD-2) London School of Hygiene and Tropical Medicine 01/01/2013
Coleman, Professor Nicholas nc109**[ta]**.ac.uk
Viral and host mechanisms in cervical carcinogenesis: towards improved clinical management University of Cambridge 01/11/2011
Coleman, Professor Robert r.e.coleman**[ta]**feld.ac.uk
CRUKE/03/017: AZURE - Bone Health Sub-protocol: Bone health in breast cancer survivors following adjuvant bisphosphonate
Collins, Dr Ian ian.collins**[ta]**.ac.uk
Preclinical development & CRUKD/16/
Collis, Dr Spencer s.collis**[ta]**feld.ac.uk
The identifcation and characterisation of novel genome maintenance factors University of Shefeld 01/09/2010
The above is a list of Cancer Research
CRUK/06/018: A
Cook, Dr Simon simon.cook**[ta]**raham.ac.uk
Understanding and overcoming resistance to MEK1/2 inhibitors in tumour cells Babraham Institute 01/01/2013
Coombes, Professor Raoul New Approaches to Reverse Endocrine Resistance in
Copson, Dr Ellen E.Copson**[ta]**on.ac.uk
Know Your Numbers (KYN): Adding Primary Prevention to the
Corrie, Dr Pippa pippa.corrie**[ta]**enbrookes.nhs.uk
CRUK/06/014: ****AST-M: A randomised trial evaluating the VEGF inhibitor, Bevacizumab (Avastin®), as adjuvant therapy following resection of AJCC stage IIB (T3bN